Last reviewed · How we verify
NCT04550403
Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes
trial in Diabetes Mellitus in 757 participants. Completed in 31 December 2021.
30 October 2021
Quick facts
| Lead sponsor | Azienda Ospedaliero-Universitaria di Parma |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 757 |
| Start date | 30 July 2020 |
| Primary completion | 30 October 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Italy |
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
- Covid19 — all drugs for Covid19 →
Sponsor
Azienda Ospedaliero-Universitaria di Parma — full company profile →
Who can join
Eligibility, any sex, with Diabetes Mellitus or Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with diabetes have been listed as people at higher risk for severe illness from COVID-19. Moreover, the relationship between diabetes-related phenotypes and the severity of COVID-19 remains unknown. This observational study aims to to evaluate the risk of disease severity and mortality in association with diabetes in COVID-19 inpatients and identify the clinical and biological features associated with worse outcomes.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
58<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : Stockholm, Sweden, 19 - 23 September 2022.
· 2022 · cited 6× · PMID 35920845 · DOI 10.1007/s00125-022-05755-w -
Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19.
Dei Cas A, Aldigeri R, Eletto E, Ticinesi A, et al · · 2025 · cited 1× · PMID 40314776 · DOI 10.1007/s00592-025-02507-1
Verify or expand the search:
- PubMed search for NCT04550403
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Azienda Ospedaliero-Universitaria di Parma trials
Trials by the same sponsor.
- NCT07360366 — Interprofessional Collaboration in the Cardiac Intensive Care Unit (CICU): An Action-Research Training Project · NA · not yet recruiting
- NCT06888167 — Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function. · NA · recruiting
- NCT06876818 — Predictive Cardio-Metabolic Trascrictomics Trajectories In The Barilla Offspring Follow-Up Study · active not recruiting
- NCT07419178 — A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemoki · NA · recruiting
- NCT05936944 — Role of Natural Light in the Prevention of Delirium After Cardiac Surgery: a Prospective Observational Study With Histor · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04550403 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria di Parma
- Last refreshed: 17 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04550403.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing